Pristyn Care is a healthtech startup based in Gurugram, India, that provides surgical care through clinics and hospitals for patients needing elective procedures.

This Startup Deep Dive explains what Pristyn Care does, how it makes money, who backs it, how it compares with rivals and what could go wrong, using publicly available information. It is educational and not investment advice. Last updated: October 2026.

Pristyn Care in Brief

• What it is: Pristyn Care is an Indian Surgical care and hospitals company based in Gurugram.
• Who it serves: patients, doctors, hospitals, diagnostic centres, insurers and employers.
• Pristyn Care offers surgical care and related treatments to patients in India through its own clinics and partner hospitals.
• The company claims presence in over 30 cities, about 100 clinics and over 200 partner hospitals (company-stated).
• It has been shifting from an asset-light model toward owned hospitals (reported).
• Funding: About $177M to $181M (reported; sources differ).

Pristyn Care Quick Facts

Figures marked “reported” come from published reports and may differ between sources; “Not disclosed” means no reliable public figure was found.

What Is Pristyn Care?

Pristyn Care operates in the Surgical care and hospitals space in India. Understanding a company like this starts with three questions: who is the customer, what painful problem is being solved, and why the solution is better than the alternatives. The sections below apply that lens to Pristyn Care.

• Pristyn Care offers surgical care and related treatments to patients in India through its own clinics and partner hospitals.
• The company claims presence in over 30 cities, about 100 clinics and over 200 partner hospitals (company-stated).
• It has been shifting from an asset-light model toward owned hospitals (reported).

The Origin Story of Pristyn Care

Every company starts from a noticed gap and a team willing to commit to closing it. Strong origin stories are specific: a clear problem, a founding team with relevant skills, and an early product that real customers could test. Founder-market fit, meaning the team’s lived experience or technical depth in the domain, tends to predict how fast a young company learns.

• Founders: Harsimarbir Singh, Dr. Vaibhav Kapoor, Dr. Garima Sawhney.
• Pristyn Care was founded in 2018 in Gurugram by Harsimarbir Singh, Dr. Vaibhav Kapoor and Dr. Garima Sawhney.

Key Milestones and Challenges

No startup grows in a straight line. Early years usually involve slow adoption, product rewrites, hiring mistakes and funding gaps. In the Surgical care and hospitals sector the common turning points are a first paying customer, a regulatory approval, a successful product demonstration or a funding round that lets the team invest ahead of demand. How a team responds to setbacks says more about resilience than any single headline.

• 2018: Founded.
• Sequoia Capital reportedly valued the company at $1.4B, giving it unicorn status.
• 2024: Reportedly exited six tier-II cities including Kanpur, Siliguri and Ludhiana and laid off about 120 employees.
• July 2025: Raised $4M from existing investors at a reported flat valuation.

Pristyn Care Funding and Investors

Funding history shows how much outside confidence a company has attracted and how long it can operate before needing more capital. Figures below are reported and may differ between sources; valuation figures are estimates unless the company has confirmed them.

• Total of about $181M across 6 rounds per one source (reported).
• July 2025: $4M (about INR 33.8 crore) from Peak XV Partners and Hummingbird Ventures (reported).

How Does Pristyn Care Make Money? (Business Model)

A business model describes who pays, how often and how much it costs to serve them. Strong models show repeat usage, improving margins with scale and acquisition channels that do not depend only on paid spend. Weak models show one-off sales, rising costs and growth that stops when spending stops. For companies selling to patients, doctors, hospitals, diagnostic centres, insurers and employers, sales cycles and contract size matter as much as headline growth.

• The company earns from surgical procedures and treatments delivered via its clinics and partner or owned hospitals.
• It is moving toward owned facilities from an asset-light model (reported).

The Numbers: Pristyn Care Financials

Financial figures show whether growth is turning into a self-sustaining business. Small and private companies often disclose little, so any number below is included only if it was found in public reporting.

• FY24 operating revenue about INR 600 crore, up about 33% from about INR 453 crore in FY23, with net loss of about INR 381 crore (reported); another data page lists a different figure of INR 388.4 crore, so reports differ.
• FY24 EBITDA margin was -57% versus -78% in FY23 (reported).
• Founders collectively hold 48.1% and Sequoia Capital 23.4% as of November 2025 per one cap table (reported).

Market Opportunity for Pristyn Care

Market size is easy to exaggerate, so a useful approach separates the total market from the portion a company can realistically reach with its current product and distribution. The main forces behind demand in this sector are rising chronic disease, growing health insurance penetration, government programmes such as Ayushman Bharat and the Ayushman Bharat Digital Mission, and the shift of care to digital and home settings. Each of these widens the opportunity, but capital efficiency and execution decide who captures it.

• Pristyn Care operates in India's elective surgery and hospital care market.

Technology and Product at Pristyn Care

Technology is rarely the whole moat, but it drives speed, cost and customer experience. A practical way to assess it is to separate the capability the company controls from the commodity infrastructure it rents. In this sector the important factors are clinical validity, data quality, integration with hospital and lab systems, and trust among doctors and patients.

• Core capability: Public detail on Pristyn Care’s technology stack is limited beyond company-stated descriptions.
• Assessment lens: clinical validity, data quality, integration with hospital and lab systems, and trust among doctors and patients.

Team and Culture at Pristyn Care

Teams are the most important and least measurable asset of a young company. Look at how complementary the founders’ skills are, how deep the second layer of leadership is, and how the company hires and retains specialists. Culture shows up in small repeated behaviours: how quickly bad news travels upward and whether commitments to customers are kept.

• Founders collectively hold 48.1% equity (reported).

Pristyn Care Competitors: Competitive Landscape

A fair competitive analysis names direct rivals, adjacent players who could move into the space, and the customer’s default alternative. Durable advantages include proprietary data or technology, licences and approvals, brand trust, switching costs and cost leadership.

Risks and Challenges for Pristyn Care

• FY24 net loss of about INR 381 crore remained flat despite revenue growth.
• Reports in 2025 described senior executive exits and a cash crunch (reported).
• The July 2025 round was small and at a flat valuation.
• Regulatory risk: medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules.
• Clinical and liability risk: errors in care, diagnosis or product quality can damage trust quickly.

Risk is not a reason to avoid a company; it is a reason to price it correctly and to monitor the right indicators over time. Regulation in this sector is shaped by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Pristyn Care Growth Outlook: What to Watch

• Reports say the company is preparing for an IPO within the next three years (reported).
• The company shifted strategy toward owned hospitals and reportedly aimed for about INR 900 crore FY25 revenue; no source confirmed whether it was met.
• Key indicators: patient or user volumes, repeat usage, gross margin, clinical outcomes and cost of acquiring each customer.
• Funding position: Whether Pristyn Care can reach its next milestone before needing new capital.
• Regulation: Changes from the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Industry Context: Where Pristyn Care Fits

India's healthcare market combines a large public system, a fast-growing private hospital sector and an increasingly digital layer. Government initiatives such as Ayushman Bharat and the Ayushman Bharat Digital Mission aim to widen insurance cover and create common digital health records, while telemedicine guidelines and the Digital Personal Data Protection Act shape how digital care and patient data can be used.

Demand is driven by chronic and lifestyle disease, an ageing population, rising insurance penetration and consumers who now expect to book, pay and consult online. Startups in this field compete on trust, clinical quality and convenience, and they must prove outcomes and safety as well as growth.

For readers new to this field, a useful habit is to separate announcements from evidence. A plan, a partnership or a funding headline describes intent, while a delivered product, a paying customer or an audited financial statement describes results. Comparing the two over time shows how reliably a company turns promises into outcomes.

Bull Case and Bear Case for Pristyn Care

An investment thesis is a short, testable statement of why a company could become far more valuable, together with what evidence would prove it wrong. The points below are general to this sector and are not forecasts for Pristyn Care.

Bull case

• Rising insurance cover and digital adoption expand the customer base.
• Strong clinical evidence builds trust with doctors and hospitals.
• Scale can improve unit economics in diagnostics and care delivery.

Bear case

• Regulatory changes can alter permitted products or business models.
• Customer acquisition costs can erode margins.
• A single safety or privacy incident can damage trust.

Lessons Founders and Investors Can Take from Pristyn Care

Studying a company in the Surgical care and hospitals space offers lessons that go beyond any single firm. The points below are general lessons for the sector and are not claims about Pristyn Care.

• Trust is the real currency in healthcare, so quality control, clinical evidence and data protection must be built in from the start.
• Distribution through hospitals, clinics, insurers or employers can matter more than a standalone consumer app.
• Unit economics improve when repeat usage replaces expensive one-time customer acquisition.
• Regulatory approvals can take time, so timelines and cash planning should allow for them.
• Integration with existing hospital, lab and records systems reduces friction for adoption.

How to Evaluate Pristyn Care as a Startup

• Customer clarity: Can Pristyn Care name its customer and the problem it solves in one sentence?
• Evidence of demand: Look for repeat customers, signed contracts or measurable usage rather than announcements alone.
• Economics: Check whether margins improve as volume grows.
• Execution: Compare announced timelines with what has actually been delivered.
• Funding runway: Estimate how long current capital lasts at the present spending rate.
• Regulatory standing: Confirm required approvals are in place.
• Customer concentration: Check whether a few customers account for most of the revenue.
• Management depth: Look for experienced leaders beyond the founders and a stable core team.

The Takeaway

Pristyn Care is part of India’s growing Surgical care and hospitals ecosystem. The useful lesson from studying it is the discipline of asking structured questions about customers, economics, advantage and resilience. Companies that answer them well, repeatedly and under pressure are the ones that endure. This article is educational and is not investment advice.

• Clear customers and repeat demand matter more than announcements.
• Regulation and capital needs shape how fast a startup in this sector can grow.
• Track a few leading indicators over time rather than one headline metric.

Pristyn Care FAQs: Frequently Asked Questions

What is Pristyn Care?

Pristyn Care is a healthtech startup based in Gurugram, India, that provides surgical care through clinics and hospitals for patients needing elective procedures. It is profiled in the Startup Deep Dive series, which explains business model, funding, competitors and risks.

Who founded Pristyn Care?

Pristyn Care was founded by Harsimarbir Singh, Dr. Vaibhav Kapoor, Dr. Garima Sawhney, and the company reports a founding year of 2018.

How much funding has Pristyn Care raised?

About $177M to $181M (reported; sources differ). Funding figures are reported and may differ between sources, so readers should check the latest company announcements.

How does Pristyn Care make money?

Pristyn Care earns revenue from its Surgical care and hospitals products and services sold to patients, doctors, hospitals, diagnostic centres, insurers and employers. The exact revenue mix is described in the business model section and is not fully disclosed publicly.

Who are the competitors of Pristyn Care?

Reported rivals include Practo, PharmEasy, MediBuddy. See the competitor comparison above for how they differ.

What are the main risks for Pristyn Care?

Main risks include medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules, funding and capital needs, competition and regulation by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act. This is educational content, not investment advice.

Related Startup Deep Dives: Nibiru Aerospace — short profile of what is publicly known | Paytm — from the RBI bank ban to its first full-year profit. Browse the full Startup Deep Dive series.

Source

Source: Publicly available data, published reports, industry research, and other credible sources.